Filters & Sorting

New Hampshire's GOP are taking a stand—against the polio vaccine

New Hampshire could soon beat Florida—known for its anti-vaccine Surgeon General—when it comes to loosening vaccine requirements. A first-in-the-nation bill that’s already passed New Hampshire’s state House, sponsored only by Republican legislators, would end the requirement for parents enrolling kids in childcare to provide documentation of polio and measles vaccination. New Hampshire would be the only state in the US to have such a law, although many states allow religious exemptions to vaccin

Millions of Americans will soon lose web access. That's a crisis for rural health.

On New Year’s Eve 2021, the federal government launched the Affordable Connectivity Program, which has helped over 20 million American households afford internet access with monthly subsidies of $30 (or up to $75 on some tribal lands). But funding for the program is set to run out in April unless Congress acts by Friday—depriving many of those homes of vital resources, especially access to online telehealth.

What we lose by armchair diagnosing Biden and Trump

Last week, a special counsel report looking into President Biden’s handling of classified documents described the president’s memory as “poor,” with “significant limitations.” Speculation about Biden’s cognitive state immediately followed. In its coverage, Fox News featured a doctor—not Biden’s—who said the president had symptoms of age-related dementia. Also stopping by the network was Republican Sen. Marco Rubio, who said Biden either had dementia or should be charged with a crime. Some Democr

Will California keep funding sickle cell care?

In June 2019, California Gov. Gavin Newsom signed the state’s annual budget into law—which that year included around $15 million (of some $215 billion total) to create and fund a statewide network of treatment centers for sickle cell disease, with training for health workers and improved diagnostic screening. Sickle cell disease, a group of rare genetic disorders characterized by abnormal hemoglobin, can be very painful, cause reduced life expectancy, and involve complications like severe anemi

Congress incentivizes rare disease research. Big Pharma exploits it.

After three years on prednisone, a steroid not recommended for long-term use, Amy G. saw a new specialist. She had been diagnosed with EGPA, a particularly rare type of the autoimmune disorder vasculitis, which causes blood vessels to be inflamed. When it’s not properly managed, people with EGPA—roughly five in every 200,000 adults—risk potentially fatal complications, including bleeding in the lungs. The doctor wanted to start her on Rituximab, a biologic medication that has been found to help.

Our transplant network wastes 25,000 organs a year. We're finally fixing it.

A bipartisan bill to reform the national organ donor network has reached President Joe Biden’s desk, spelling the likely end of a troubled monopoly in place for close to four decades. Signed, the law will let HHS officials, who have commended the changes, award multiple federal contracts to manage the network—part of a wider plan to secure better oversight and more transplants each year.